These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15159324

  • 1. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
    Ulrich CM, Bigler J, Sparks R, Whitton J, Sibert JG, Goode EL, Yasui Y, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
    [Abstract] [Full Text] [Related]

  • 2. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps.
    Poole EM, Bigler J, Whitton J, Sibert JG, Potter JD, Ulrich CM.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708
    [Abstract] [Full Text] [Related]

  • 3. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
    Potter JD, Bigler J, Fosdick L, Bostick RM, Kampman E, Chen C, Louis TA, Grambsch P.
    Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.
    Huang EH, Whelan RL, Gleason NR, Maeda JS, Terry MB, Lee SW, Neugut AI, Forde KA.
    Surg Endosc; 2001 Jul; 15(7):646-8. PubMed ID: 11591960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?
    Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1012-8. PubMed ID: 12376501
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for advanced colorectal adenomas: a pooled analysis.
    Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas.
    Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD.
    Cancer Res; 2002 Jun 15; 62(12):3361-4. PubMed ID: 12067974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.
    Gastroenterology; 2005 Aug 15; 129(2):464-75. PubMed ID: 16083703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.